Keryx Biopharmaceuticals Inc (NASDAQ:KERX)

9.67
Delayed Data
As of Jul 02
 -0.17 / -1.73%
Today’s Change
8.84
Today|||52-Week Range
18.48
-31.66%
Year-to-Date

Stock Price Forecast

The 10 analysts offering 12-month price forecasts for Keryx Biopharmaceuticals Inc have a median target of 21.00, with a high estimate of 29.00 and a low estimate of 17.00. The median estimate represents a +117.17% increase from the last price of 9.67.

Analyst Recommendations

The current consensus among 11 polled investment analysts is to Buy stock in Keryx Biopharmaceuticals Inc. This rating has held steady since June, when it was unchanged from a Buy rating.Move your mouse over past
months for detail

 
 
 
 
 
 
 
 

Earnings and Sales Forecasts

Current Quarter

Earnings per Share
-$0.26
Sales
$2.8M
Reporting Date
Aug 10

Earnings per Share

Move your mouse over a quarter or year to see how estimates have changed over time.

Growthquarterly 8.33%
 
 
 
 
 
 
Growthannually 23.86%
 
 
 
 
 
 

Sales

Growthquarterly 142.02%
 
 
 
 
 
 
Growthannually 160.34%
 
 
 
 
 
 
Key to the earnings and sales forecast charts.

To view my watchlist

Not a member yet?

Sign up now for a free account